GeneDx plunges after trimming annual revenue forecast

GeneDx Holdings

04/05/2026 21:46

** Shares of genomics firm GeneDx WGS.O fall 43% to $38.69 in extended trading

** Co lowers annual revenue forecast to between $475 million and $490 million, compared to previous projection of $540 million to $555 million

** Reports Q1 revenue of $102.3 million, missing analysts' average estimate of $112.96 million, according to data compiled by LSEG

** WGS down ~48% YTD

(Reporting by Padmanabhan Ananthan)

((Padmanabhan.Ananthan@thomsonreuters.com))